S169: CLINICAL AND MOLECULAR MARKERS FOR PREDICTING RESPONSE TO ROMIPLOSTIM TREATMENT IN LOWER-RISK MYELODYSPLASTIC SYNDROMES - A. S. Kubasch; A. Giagounidis; G. Metzgeroth; A. Jonasova; R. Herbst; J. M. T. Diaz; B. De Renzis; K. S. Götze; M.-L. Huetter-Kroenke; M.-P. Gourin; B. Slama; S. Dimicoli-Salazar; et al. (HemaSphere, 2022)